Product Code: ETC070005 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The market for contract cell and gene therapy manufacturing in Malaysia is expected to witness significant growth over the forecast period. This can be attributed to rising number of government initiatives, such as grants and subsidies by the Malaysia Government, which are encouraging research & development activities related to biopharmaceuticals and regenerative medicine. Additionally, increasing investments by private players in biotechnology companies operating in Malaysia is also driving the market growth. Moreover, increasing demand for patient-specific treatments owing to growing prevalence of chronic diseases is anticipated to further boost the market
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2020 & 2027F |
3.3 Malaysia Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Malaysia Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2020 & 2027F |
3.6 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Malaysia Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Malaysia Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Malaysia Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2027F |
6.1.3 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2027F |
6.1.4 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2027F |
6.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2027F |
6.2.3 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2027F |
6.2.4 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2027F |
6.2.5 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2027F |
7 Malaysia Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Malaysia Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Malaysia Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Malaysia Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Malaysia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2020 & 2027F |
9.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2020 & 2027F |
10 Malaysia Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Malaysia Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2020 |
10.2 Malaysia Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |